Annual Gross Profit
$1.85 B
+$381.90 M+26.06%
31 December 2023
Summary:
Neurocrine Biosciences annual gross profit is currently $1.85 billion, with the most recent change of +$381.90 million (+26.06%) on 31 December 2023. During the last 3 years, it has risen by +$811.60 million (+78.35%). NBIX annual gross profit is now at all-time high.NBIX Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$614.10 M
+$33.10 M+5.70%
30 September 2024
Summary:
Neurocrine Biosciences quarterly gross profit is currently $614.10 million, with the most recent change of +$33.10 million (+5.70%) on 30 September 2024. Over the past year, it has increased by +$126.50 million (+25.94%). NBIX quarterly gross profit is now at all-time high.NBIX Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$2.21 B
+$126.50 M+6.07%
30 September 2024
Summary:
Neurocrine Biosciences TTM gross profit is currently $2.21 billion, with the most recent change of +$126.50 million (+6.07%) on 30 September 2024. Over the past year, it has increased by +$464.60 million (+26.62%). NBIX TTM gross profit is now at all-time high.NBIX TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBIX Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.1% | +25.9% | +26.6% |
| 3 y3 years | +78.3% | +110.5% | +109.2% |
| 5 y5 years | +313.9% | +179.3% | +230.3% |
NBIX Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +78.3% | at high | +110.5% | at high | +109.2% |
| 5 y | 5 years | at high | +313.9% | at high | +179.3% | at high | +230.3% |
| alltime | all time | at high | >+9999.0% | at high | at high |
Neurocrine Biosciences Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $614.10 M(+5.7%) | $2.21 B(+6.1%) |
| June 2024 | - | $581.00 M(+14.4%) | $2.08 B(+7.2%) |
| Mar 2024 | - | $507.80 M(+0.2%) | $1.94 B(+5.2%) |
| Dec 2023 | $1.85 B(+26.1%) | $506.70 M(+3.9%) | $1.85 B(+5.9%) |
| Sept 2023 | - | $487.60 M(+10.5%) | $1.75 B(+6.5%) |
| June 2023 | - | $441.20 M(+7.1%) | $1.64 B(+4.3%) |
| Mar 2023 | - | $411.90 M(+1.9%) | $1.57 B(+7.2%) |
| Dec 2022 | $1.47 B(+30.9%) | $404.30 M(+5.9%) | $1.47 B(+7.0%) |
| Sept 2022 | - | $381.80 M(+2.2%) | $1.37 B(+7.0%) |
| June 2022 | - | $373.40 M(+22.0%) | $1.28 B(+7.4%) |
| Mar 2022 | - | $306.00 M(-0.6%) | $1.19 B(+6.5%) |
| Dec 2021 | $1.12 B(+8.1%) | $307.90 M(+5.5%) | $1.12 B(+6.0%) |
| Sept 2021 | - | $291.80 M(+2.1%) | $1.06 B(+3.5%) |
| June 2021 | - | $285.80 M(+22.3%) | $1.02 B(-1.4%) |
| Mar 2021 | - | $233.70 M(-4.6%) | $1.03 B(-0.1%) |
| Dec 2020 | $1.04 B(+32.7%) | $245.00 M(-4.2%) | $1.04 B(+0.3%) |
| Sept 2020 | - | $255.80 M(-14.7%) | $1.03 B(+3.6%) |
| June 2020 | - | $300.00 M(+27.7%) | $996.50 M(+13.4%) |
| Mar 2020 | - | $235.00 M(-2.7%) | $878.40 M(+12.5%) |
| Dec 2019 | $780.70 M(+74.9%) | $241.60 M(+9.9%) | $780.70 M(+16.7%) |
| Sept 2019 | - | $219.90 M(+20.9%) | $669.01 M(+11.6%) |
| June 2019 | - | $181.90 M(+32.5%) | $599.31 M(+16.7%) |
| Mar 2019 | - | $137.30 M(+5.7%) | $513.46 M(+15.0%) |
| Dec 2018 | $446.30 M(+178.3%) | $129.91 M(-13.5%) | $446.30 M(+8.8%) |
| Sept 2018 | - | $150.21 M(+56.4%) | $410.15 M(+28.1%) |
| June 2018 | - | $96.05 M(+36.9%) | $320.29 M(+38.9%) |
| Mar 2018 | - | $70.14 M(-25.2%) | $230.51 M(+43.7%) |
| Dec 2017 | $160.37 M(+969.1%) | $93.76 M(+55.4%) | $160.37 M(+140.7%) |
| Sept 2017 | - | $60.34 M(+861.8%) | $66.61 M(+961.8%) |
| June 2017 | - | $6.27 M(>+9900.0%) | $6.27 M(>+9900.0%) |
| Mar 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2016 | $15.00 M | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2016 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2015 | $19.77 M(+569.5%) | - | - |
| Sept 2011 | - | $41.63 M(+242.5%) | $66.30 M(+69.5%) |
| June 2011 | - | $12.16 M(-2.8%) | $39.12 M(+23.8%) |
| Mar 2011 | - | $12.51 M(-13.4%) | $31.60 M(+53.5%) |
| Sept 2010 | - | $14.45 M(+211.2%) | $20.58 M(+199.7%) |
| June 2010 | - | $4.64 M(+516.6%) | $6.87 M(+132.1%) |
| Mar 2010 | - | $753.00 K(+1.8%) | $2.96 M(+0.2%) |
| Dec 2009 | $2.95 M(-25.7%) | $740.00 K(+1.0%) | $2.95 M(+33.4%) |
| Sept 2009 | - | $733.00 K(0.0%) | $2.21 M(+49.5%) |
| June 2009 | - | $733.00 K(-1.9%) | $1.48 M(+98.1%) |
| Mar 2009 | - | $747.00 K(-81.9%) | $747.00 K(-95.5%) |
| Dec 2008 | $3.98 M(-76.3%) | - | - |
| Dec 2000 | $16.79 M(-11.2%) | $4.13 M(-29.9%) | $16.79 M(-3.9%) |
| Sept 2000 | - | $5.89 M(+69.2%) | $17.46 M(+1.1%) |
| June 2000 | - | $3.48 M(+5.5%) | $17.27 M(-4.1%) |
| Mar 2000 | - | $3.30 M(-31.3%) | $18.01 M(-4.8%) |
| Dec 1999 | $18.90 M(+6.8%) | $4.80 M(-15.8%) | $18.91 M(-0.5%) |
| Sept 1999 | - | $5.70 M(+35.4%) | $19.01 M(+0.5%) |
| June 1999 | - | $4.21 M(+0.2%) | $18.91 M(+8.7%) |
| Mar 1999 | - | $4.20 M(-14.3%) | $17.40 M(-1.7%) |
| Dec 1998 | $17.70 M(-35.4%) | $4.90 M(-12.5%) | $17.70 M(-8.8%) |
| Sept 1998 | - | $5.60 M(+107.4%) | $19.40 M(-4.4%) |
| June 1998 | - | $2.70 M(-40.0%) | $20.30 M(-10.6%) |
| Mar 1998 | - | $4.50 M(-31.8%) | $22.70 M(-16.8%) |
| Dec 1997 | $27.40 M(+35.6%) | $6.60 M(+1.5%) | $27.30 M(-9.9%) |
| Sept 1997 | - | $6.50 M(+27.5%) | $30.30 M(+15.2%) |
| June 1997 | - | $5.10 M(-44.0%) | $26.30 M(-2.2%) |
| Mar 1997 | - | $9.10 M(-5.2%) | $26.90 M(+33.2%) |
| Dec 1996 | $20.20 M | $9.60 M(+284.0%) | $20.20 M(+90.6%) |
| Sept 1996 | - | $2.50 M(-56.1%) | $10.60 M(+30.9%) |
| June 1996 | - | $5.70 M(+137.5%) | $8.10 M(+237.5%) |
| Mar 1996 | - | $2.40 M | $2.40 M |
FAQ
- What is Neurocrine Biosciences annual gross profit?
- What is the all time high annual gross profit for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual gross profit year-on-year change?
- What is Neurocrine Biosciences quarterly gross profit?
- What is the all time high quarterly gross profit for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly gross profit year-on-year change?
- What is Neurocrine Biosciences TTM gross profit?
- What is the all time high TTM gross profit for Neurocrine Biosciences?
- What is Neurocrine Biosciences TTM gross profit year-on-year change?
What is Neurocrine Biosciences annual gross profit?
The current annual gross profit of NBIX is $1.85 B
What is the all time high annual gross profit for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual gross profit is $1.85 B
What is Neurocrine Biosciences annual gross profit year-on-year change?
Over the past year, NBIX annual gross profit has changed by +$381.90 M (+26.06%)
What is Neurocrine Biosciences quarterly gross profit?
The current quarterly gross profit of NBIX is $614.10 M
What is the all time high quarterly gross profit for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly gross profit is $614.10 M
What is Neurocrine Biosciences quarterly gross profit year-on-year change?
Over the past year, NBIX quarterly gross profit has changed by +$126.50 M (+25.94%)
What is Neurocrine Biosciences TTM gross profit?
The current TTM gross profit of NBIX is $2.21 B
What is the all time high TTM gross profit for Neurocrine Biosciences?
Neurocrine Biosciences all-time high TTM gross profit is $2.21 B
What is Neurocrine Biosciences TTM gross profit year-on-year change?
Over the past year, NBIX TTM gross profit has changed by +$464.60 M (+26.62%)